Valuation: Bayer AG

Market Cap 47.63B 55.58B 44.56B 40.74B 76.87B 5,321B 77.69B 527B 205B 2,672B 209B 204B 8,841B P/E 2026 *
20.7x
P/E 2027 * 15.5x
Enterprise Value 77.71B 90.67B 72.7B 66.46B 125B 8,682B 127B 860B 334B 4,360B 340B 333B 14,425B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.59x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.09%
1 week-0.96%
Current month-0.96%
1 month+0.68%
3 months+26.04%
6 months+13.51%
Current year+34.29%
1 week 206.7
Extreme 206.7
212.4
1 month 205
Extreme 205
214.1
3 years 78.97
Extreme 78.97
241
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 60 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
+1.84%-0.96%+69.09%-9.99% 55.58B
+0.81%+5.39%+75.21%+127.54% 1,111B
-0.72%+4.07%+52.29%+65.39% 658B
+0.27%+5.67%+25.60%+80.40% 467B
+0.30%+2.72%+42.63%+43.02% 369B
+0.36%+1.10%+25.39%+41.48% 301B
+1.16%+3.42%+2.85%+14.54% 256B
+0.22%+5.83%+51.11%+72.96% 240B
+2.95%+3.49%-16.50%-52.00% 207B
+0.31%+5.63%+27.86%+92.24% 182B
Average +0.73%+4.49%+35.55%+47.56% 421.22B
Weighted average by Cap. +0.59%+4.68%+44.67%+72.12%

Financials

2026 *2027 *
Net sales 45.75B 53.38B 42.8B 39.13B 73.84B 5,111B 74.62B 506B 197B 2,567B 200B 196B 8,492B 46.97B 54.81B 43.94B 40.17B 75.81B 5,248B 76.61B 520B 202B 2,635B 206B 201B 8,719B
Net income 2.13B 2.49B 1.99B 1.82B 3.44B 238B 3.48B 23.6B 9.18B 120B 9.34B 9.14B 396B 2.95B 3.44B 2.76B 2.52B 4.76B 329B 4.81B 32.63B 12.69B 165B 12.91B 12.63B 547B
Net Debt 30.08B 35.1B 28.14B 25.73B 48.55B 3,361B 49.06B 333B 129B 1,688B 132B 129B 5,583B 26.9B 31.39B 25.16B 23.01B 43.41B 3,005B 43.88B 298B 116B 1,509B 118B 115B 4,993B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
26-08-25 PLN 210.50 +1.84%
26-08-24 PLN 206.70 0.00%
26-08-21 PLN 206.70 -2.68%
26-08-20 PLN 212.40 0.00%
26-08-19 PLN 212.40 +1.77%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.48EUR
Average target price
56.83EUR
Spread / Average Target
+17.23%

Quarterly revenue - Rate of surprise